Windtree Therapeutics is a biopharmaceutical company focused on the development of therapeutics. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. Co.'s heart failure cardiovascular portfolio also includes sarco endoplasmic reticulum Ca2+ -ATPase 2a (SERCA2a) activators. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds. In addition, Co.'s cardiovascular drug product candidates include rostafuroxin, a product candidate for the treatment of hypertension in patients with a specific genetic profile. We show 17 historical shares outstanding datapoints in our WINT shares outstanding history coverage, used to compute WINT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing WINT market cap history over the course of time is important for investors
interested in comparing WINT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of WINT versus a peer is one thing; comparing
WINT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like WINT can fluctuate over the course of history.
With this page we aim to empower investors researching WINT by allowing them to research the WINT market cap history. |
Free WINT Email Alerts:
Video: The Importance of Market Cap
